244 related articles for article (PubMed ID: 29166609)
1. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
[TBL] [Abstract][Full Text] [Related]
2. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
3. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition.
Ganesh RA; Sonpatki P; Naik D; John AE; Sathe G; Lakshmikantha A; Chandrachari KP; Bauer L; Knäuper V; Aeschlimann D; Venkatraaman K; Shah N; Sirdeshmukh R
Front Oncol; 2022; 12():841890. PubMed ID: 35600402
[TBL] [Abstract][Full Text] [Related]
5. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
[TBL] [Abstract][Full Text] [Related]
6. GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma.
Ganesh RA; Venkataraman K; Sirdeshmukh R
J Cell Commun Signal; 2023 Dec; 17(4):1527-1535. PubMed ID: 37980704
[TBL] [Abstract][Full Text] [Related]
7. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
[TBL] [Abstract][Full Text] [Related]
9. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
10. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
11. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
Hai L; Zhang C; Li T; Zhou X; Liu B; Li S; Zhu M; Lin Y; Yu S; Zhang K; Ren B; Ming H; Huang Y; Chen L; Zhao P; Zhou H; Jiang T; Yang X
Cell Death Dis; 2018 Feb; 9(2):158. PubMed ID: 29410396
[TBL] [Abstract][Full Text] [Related]
12. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
Cai J; Zhang J; Wu P; Yang W; Ye Q; Chen Q; Jiang C
J Neurooncol; 2018 Nov; 140(2):225-236. PubMed ID: 30043319
[TBL] [Abstract][Full Text] [Related]
13. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS
Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951
[TBL] [Abstract][Full Text] [Related]
14. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
[TBL] [Abstract][Full Text] [Related]
16. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
[TBL] [Abstract][Full Text] [Related]
17. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
18. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
[No Abstract] [Full Text] [Related]
19. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y
Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883
[TBL] [Abstract][Full Text] [Related]
20. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion.
Shashidhar S; Lorente G; Nagavarapu U; Nelson A; Kuo J; Cummins J; Nikolich K; Urfer R; Foehr ED
Oncogene; 2005 Mar; 24(10):1673-82. PubMed ID: 15674329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
